Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 13,698 shares at $69.02 ($945K) on 2025-10-06, disclosed to the SEC on 2025-10-08.
Scheduled sale ($945k) by EVP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.02 | 6,849 | $473K | 50.0% |
| 2 | $69.02 | 6,849 | $473K | 50.0% |
| Total | $69.02 avg | 13,698 | $945K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |